The Biggest Technology Failures of 2016
The world’s most expensive medicine
The most expensive drug on the planet is Glybera. It’s famous for being the first gene therapy ever approved in Europe and for its eye-popping price tag of $1 million. But what we learned this year is that the drug, for a rare metabolic condition, has only ever been given once, due to concerns over its cost and how well it works. Instead of being a history-making start to the era of DNA replacement, Glybera is a complete bust for its creator, the gene-therapy startup called UniQure.
The inside story of how ChatGPT was built from the people who made it
Exclusive conversations that take us behind the scenes of a cultural phenomenon.
How Rust went from a side project to the world’s most-loved programming language
For decades, coders wrote critical systems in C and C++. Now they turn to Rust.
Design thinking was supposed to fix the world. Where did it go wrong?
An approach that promised to democratize design may have done the opposite.
Sam Altman invested $180 million into a company trying to delay death
Can anti-aging breakthroughs add 10 healthy years to the human life span? The CEO of OpenAI is paying to find out.
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.